From 10-Q for Q1 2018.......... " Near the end of the quarter we learned that a competitor in providing services to correctional facilities was planning on exiting the business. Throughout the first several weeks of the current quarter (the 2nd fiscal quarter) we have been working with correctional facilities to minimize the impact of this transition. Over time, we believe that this will be beneficial for CompuMed,....." My take: Sale going forward would likely be in the 30%+ q/q; cost 52%**(in q1) is a bit higher than 48% that I was expecting; sg&a 39%(in q1) should be the norm in 2018 vs 45% in 2017.
**higher by few % points,most likely due to the extra effort getting the correctional facilities contract back.
ps-sale for Q2 may top $750K.Woooooooowwwwwwwwwww.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.